| Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia (NCT00005986) | Masonic Cancer Center, University of Minnesota | 2000-08-01 |
| Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia (NCT00022035) | Roswell Park Cancer Institute | 2000-08-01 |
| Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia (NCT00005984) | Masonic Cancer Center, University of Minnesota | 2000-08-01 |
| A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy (NCT00261677) | Ortho Biotech Products, L.P. | 2000-08-01 |
| Allogeneic Transplantation From Related Haploidentical Donors (NCT00185692) | Stanford University | 2000-08-01 |
| Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia (NCT00430118) | University Hospital Schleswig-Holstein | 2000-07-01 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283) | Fred Hutchinson Cancer Center | 2000-07-01 |
| flt3L in Treating Patients With Acute Myeloid Leukemia (NCT00006223) | Eastern Cooperative Oncology Group | 2000-07-01 |
| Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders (NCT00582621) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia (NCT00006020) | SWOG Cancer Research Network | 2000-07-01 |
| Evaluating the Use of RFT5-dgA to Deplete Alloreactive Cells Prior to Haploidentical Stem Cell Transplantation (NCT00586547) | Baylor College of Medicine | 2000-07-01 |
| Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment (NCT00006091) | M.D. Anderson Cancer Center | 2000-06-19 |
| STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa (NCT00006053) | Novartis | 2000-06-01 |
| Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H (NCT00048412) | Baylor College of Medicine | 2000-06-01 |
| Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer (NCT00365287) | Masonic Cancer Center, University of Minnesota | 2000-06-01 |
| Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies (NCT00038207) | M.D. Anderson Cancer Center | 2000-06-01 |
| STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia (NCT00006052) | Novartis | 2000-06-01 |
| STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia (NCT00006343) | Novartis | 2000-06-01 |
| Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia (NCT00006122) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-06-01 |
| Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia (NCT00005945) | Children's Oncology Group | 2000-06-01 |
| Non-Ablative Allo HSCT For Hematologic Malignancies or SAA (NCT00006379) | Case Comprehensive Cancer Center | 2000-06-01 |
| Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT00006008) | Eastern Cooperative Oncology Group | 2000-06-01 |
| Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia (NCT00006090) | M.D. Anderson Cancer Center | 2000-06-01 |
| Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer (NCT00006019) | Memorial Sloan Kettering Cancer Center | 2000-05-01 |
| Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00004871) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-05-01 |
| Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00005596) | Children's Oncology Group | 2000-04-01 |
| PS-341 in Treating Patients With Hematologic Cancer (NCT00006098) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia (NCT00006040) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter (NCT00006083) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Quality of Life in Children Treated for Cancer (NCT00005881) | Children's Oncology Group | 2000-04-01 |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia (NCT00005585) | Children's Oncology Group | 2000-04-01 |
| Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia (NCT00003764) | Eastern Cooperative Oncology Group | 2000-03-09 |
| Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation (NCT00004255) | Chimeric Therapies | 2000-03-01 |
| Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood (NCT00143884) | University of Michigan Rogel Cancer Center | 2000-03-01 |
| Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma (NCT00020111) | National Cancer Institute (NCI) | 2000-03-01 |
| Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia (NCT00006045) | Facet Biotech | 2000-03-01 |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia (NCT00005603) | Children's Oncology Group | 2000-03-01 |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (NCT00004858) | Parker Hughes Cancer Center | 2000-03-01 |
| Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer (NCT00534430) | City of Hope Medical Center | 2000-02-29 |
| Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R (NCT00534469) | City of Hope Medical Center | 2000-02-08 |
| Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia (NCT00005795) | Northwestern University | 2000-02-01 |
| Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia (NCT00005618) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia (NCT00005866) | SWOG Cancer Research Network | 2000-02-01 |
| Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia (NCT00005829) | Alliance for Clinical Trials in Oncology | 2000-02-01 |
| Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation (NCT00005606) | Northwestern University | 2000-02-01 |
| Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia (NCT00005619) | Northwestern University | 2000-02-01 |
| Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy (NCT00005988) | Dana-Farber Cancer Institute | 2000-02-01 |
| S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00004217) | SWOG Cancer Research Network | 2000-02-01 |
| Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia (NCT00021151) | Case Comprehensive Cancer Center | 2000-01-01 |
| Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I (NCT02981784) | Hospices Civils de Lyon | 2000-01-01 |
| Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation (NCT00737516) | National Marrow Donor Program | 2000-01-01 |
| Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa (NCT00004933) | Alliance for Clinical Trials in Oncology | 2000-01-01 |
| Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia (NCT00004857) | Alliance for Clinical Trials in Oncology | 2000-01-01 |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia (NCT00005948) | Fred Hutchinson Cancer Center | 2000-01-01 |
| Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant (NCT00716911) | City of Hope Medical Center | 2000-01-01 |
| Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (NCT00005634) | Memorial Sloan Kettering Cancer Center | 2000-01-01 |
| Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00006350) | University of Maryland, Baltimore | 2000-01-01 |
| Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer (NCT00004132) | Jonsson Comprehensive Cancer Center | 2000-01-01 |
| EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer (NCT00004258) | Indiana University | 1999-12-01 |
| Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00004263) | M.D. Anderson Cancer Center | 1999-12-01 |
| Biological Therapy in Treating Patients With Myelodysplastic Syndrome (NCT00005853) | Fred Hutchinson Cancer Center | 1999-12-01 |
| St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer (NCT00005805) | Memorial Sloan Kettering Cancer Center | 1999-12-01 |
| Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00006042) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-12-01 |
| Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL (NCT01225874) | Children's Oncology Group | 1999-12-01 |
| 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment (NCT00004239) | Alliance for Clinical Trials in Oncology | 1999-12-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00005854) | Fred Hutchinson Cancer Center | 1999-12-01 |
| Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia (NCT00005801) | University of Colorado, Denver | 1999-11-01 |
| Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00044954) | University of Texas Southwestern Medical Center | 1999-11-01 |
| Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia (NCT00053144) | Roswell Park Cancer Institute | 1999-11-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer (NCT00006225) | Northwestern University | 1999-11-01 |
| PS-341 in Treating Patients With Advanced Cancer (NCT00006362) | Mayo Clinic | 1999-11-01 |
| Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia (NCT00003255) | Alliance for Clinical Trials in Oncology | 1999-11-01 |
| Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia (NCT00612716) | Masonic Cancer Center, University of Minnesota | 1999-10-06 |
| Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00004896) | Northwestern University | 1999-10-01 |
| Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia (NCT00019409) | National Institutes of Health Clinical Center (CC) | 1999-10-01 |
| Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT00004862) | National Cancer Institute (NCI) | 1999-10-01 |
| Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia (NCT00004898) | Northwestern University | 1999-10-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00005804) | Fred Hutchinson Cancer Center | 1999-10-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia (NCT00004905) | Loyola University | 1999-10-01 |
| Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia (NCT00004218) | Leukemia Research Fund | 1999-10-01 |
| Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004904) | Northwestern University | 1999-10-01 |
| Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00004899) | Northwestern University | 1999-10-01 |
| Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia (NCT00004181) | Northwestern University | 1999-10-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00290628) | Masonic Cancer Center, University of Minnesota | 1999-10-01 |
| Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia (NCT00004056) | Children's Oncology Group | 1999-10-01 |
| Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004232) | Northwestern University | 1999-10-01 |
| Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia (NCT00003910) | Eastern Cooperative Oncology Group | 1999-09-15 |
| 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma (NCT00003837) | National Cancer Institute (NCI) | 1999-09-01 |
| Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia (NCT00004128) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-09-01 |
| Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia (NCT00003808) | Eastern Cooperative Oncology Group | 1999-08-11 |
| Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (NCT00003829) | Alliance for Clinical Trials in Oncology | 1999-08-01 |
| Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia (NCT00004215) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia (NCT00004245) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia (NCT00006097) | Boston Medical Center | 1999-08-01 |
| Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer (NCT00019656) | National Cancer Institute (NCI) | 1999-08-01 |
| A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide (NCT00005793) | H. Lee Moffitt Cancer Center and Research Institute | 1999-07-01 |
| UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia (NCT00019838) | National Cancer Institute (NCI) | 1999-07-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia (NCT00003997) | National Cancer Institute (NCI) | 1999-07-01 |
| Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome (NCT00003593) | Children's Oncology Group | 1999-06-01 |